目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application
2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Geriatric Population
3.2.1.2. Growing Awareness for Antiaging Products
3.2.1.3. High Prevalence of Target Diseases
3.2.2. Market restraint analysis
3.2.2.1. Associated adverse effects of hyaluronic acid
3.2.2.2. High cost of products and related services
3.3. Hyaluronic Acid Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Hyaluronic Acid Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
4.4.1. Dermal fillers
4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Osteoarthritis
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2.2. Single-injection
4.4.2.2.1 Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2.3. Three-injection
4.4.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2.3. Five-injection
4.4.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Ophthalmic
4.4.3.3. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Vesicoureteral reflux
4.4.2.3. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
5.5. North America
5.5.1. U.S.
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
5.5.2. Canada
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Europe
5.6.1. UK
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
5.6.2. Germany
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
5.6.3. France
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
5.6.4. Italy
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
5.6.5. Spain
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
5.6.6. Norway
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
5.6.7. Sweden
5.6.7.1. Key country dynamics
5.6.7.2. Regulatory framework/ reimbursement structure
5.6.7.3. Competitive scenario
5.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
5.6.8. Denmark
5.6.8.1. Key country dynamics
5.6.8.2. Regulatory framework/ reimbursement structure
5.6.8.3. Competitive scenario
5.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Asia Pacific
5.7.1. Japan
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
5.7.2. China
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
5.7.3. India
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
5.7.4. Australia
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
5.7.5. South Korea
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework/ reimbursement structure
5.7.5.3. Competitive scenario
5.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
5.7.6. Thailand
5.7.6.1. Key country dynamics
5.7.6.2. Regulatory framework/ reimbursement structure
5.7.6.3. Competitive scenario
5.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
5.8.2. Mexico
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
5.8.3. Argentina
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key country dynamics
5.9.1.2. Regulatory framework/ reimbursement structure
5.9.1.3. Competitive scenario
5.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key country dynamics
5.9.2.2. Regulatory framework/ reimbursement structure
5.9.2.3. Competitive scenario
5.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
5.9.3. UAE
5.9.3.1. Key country dynamics
5.9.3.2. Regulatory framework/ reimbursement structure
5.9.3.3. Competitive scenario
5.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key country dynamics
5.9.4.2. Regulatory framework/ reimbursement structure
5.9.4.3. Competitive scenario
5.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2023
6.3.4. Allergan
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Sanofi
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Genzyme Corporation
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Anika Therapeutics, Inc.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Salix Pharmaceuticals
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Seikagaku Corporation
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. F. Hoffmann-La Roche Ag
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Galderma Laboratories L.P.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Zimmer Biomet
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Smith & Nephew Plc
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Ferring B.V.
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
6.3.15. Lifecore Biomedical, LLC
6.3.15.1. Company overview
6.3.15.2. Financial performance
6.3.15.3. Product benchmarking
6.3.15.4. Strategic initiatives
6.3.16. HTL Biotechnology
6.3.16.1. Company overview
6.3.16.2. Financial performance
6.3.16.3. Product benchmarking
6.3.16.4. Strategic initiatives
6.3.17. Shiseido Company, Limited
6.3.17.1. Company overview
6.3.17.2. Financial performance
6.3.17.3. Product benchmarking
6.3.17.4. Strategic initiatives
6.3.18. Bloomage Biotechnology Corporation Limited
6.3.18.1. Company overview
6.3.18.2. Financial performance
6.3.18.3. Product benchmarking
6.3.18.4. Strategic initiatives
6.3.19. LG Life Sciences Ltd (LG Chem.)
6.3.19.1. Company overview
6.3.19.2. Financial performance
6.3.19.3. Product benchmarking
6.3.19.4. Strategic initiatives
6.3.20. Maruha Nichiro, Inc.
6.3.20.1. Company overview
6.3.20.2. Financial performance
6.3.20.3. Product benchmarking
6.3.20.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 3 North America Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 4 U.S. Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 5 Canada Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 6 Europe Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 7 Europe Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 8 Germany Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 9 UK Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 10 France Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 11 Italy Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 12 Spain Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 13 Denmark Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 14 Sweden Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 15 Norway Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 16 Asia Pacific Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 17 Asia Pacific Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 18 China Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 19 Japan Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 20 India Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 21 South Korea Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 22 Australia Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 23 Thailand Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 24 Latin America Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 25 Latin America Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 26 Brazil Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 27 Mexico Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 28 Argentina Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 29 MEA Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 30 MEA Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 31 South Africa Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 33 UAE Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 34 Kuwait Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Hyaluronic Acid market: market outlook
Fig. 14 Hyaluronic Acid competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Hyaluronic Acid market driver impact
Fig. 20 Hyaluronic Acid market restraint impact
Fig. 21 Hyaluronic Acid market strategic initiatives analysis
Fig. 22 Hyaluronic Acid market: Application movement analysis
Fig. 23 Hyaluronic Acid market: Application outlook and key takeaways
Fig. 24 Dermal fillers market estimates and forecast, 2018 - 2030
Fig. 25 Osteoarthritis market estimates and forecast, 2018 - 2030
Fig. 26 Single-injection market estimates and forecast, 2018 - 2030
Fig. 27 Three-injection market estimates and forecast, 2018 - 2030
Fig. 28 Five-injection market estimates and forecast, 2018 - 2030
Fig. 29 Ophthalmic market estimates and forecast, 2018 - 2030
Fig. 30 Vesicoureteral reflux market estimates and forecast, 2018 - 2030
Fig. 31 Global Hyaluronic Acid market: Regional movement analysis
Fig. 32 Global Hyaluronic Acid market: Regional outlook and key takeaways
Fig. 33 Global Hyaluronic Acid market share and leading players
Fig. 34 North America market share and leading players
Fig. 35 Europe market share and leading players
Fig. 36 Asia Pacific market share and leading players
Fig. 37 Latin America market share and leading players
Fig. 38 Middle East & Africa market share and leading players
Fig. 39 North America: SWOT
Fig. 40 Europe SWOT
Fig. 41 Asia Pacific SWOT
Fig. 42 Latin America SWOT
Fig. 43 MEA SWOT
Fig. 44 North America, by country
Fig. 45 North America
Fig. 46 North America market estimates and forecasts, 2018 - 2030
Fig. 47 U.S.
Fig. 48 U.S. market estimates and forecasts, 2018 - 2030
Fig. 49 Canada
Fig. 50 Canada market estimates and forecasts, 2018 - 2030
Fig. 51 Europe
Fig. 52 Europe market estimates and forecasts, 2018 - 2030
Fig. 53 UK
Fig. 54 UK market estimates and forecasts, 2018 - 2030
Fig. 55 Germany
Fig. 56 Germany market estimates and forecasts, 2018 - 2030
Fig. 57 France
Fig. 58 France market estimates and forecasts, 2018 - 2030
Fig. 59 Italy
Fig. 60 Italy market estimates and forecasts, 2018 - 2030
Fig. 61 Spain
Fig. 62 Spain market estimates and forecasts, 2018 - 2030
Fig. 63 Denmark
Fig. 64 Denmark market estimates and forecasts, 2018 - 2030
Fig. 65 Sweden
Fig. 66 Sweden market estimates and forecasts, 2018 - 2030
Fig. 67 Norway
Fig. 68 Norway market estimates and forecasts, 2018 - 2030
Fig. 69 Asia Pacific
Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 71 China
Fig. 72 China market estimates and forecasts, 2018 - 2030
Fig. 73 Japan
Fig. 74 Japan market estimates and forecasts, 2018 - 2030
Fig. 75 India
Fig. 76 India market estimates and forecasts, 2018 - 2030
Fig. 77 Thailand
Fig. 78 Thailand market estimates and forecasts, 2018 - 2030
Fig. 79 South Korea
Fig. 80 South Korea market estimates and forecasts, 2018 - 2030
Fig. 81 Australia
Fig. 82 Australia market estimates and forecasts, 2018 - 2030
Fig. 83 Latin America
Fig. 84 Latin America market estimates and forecasts, 2018 - 2030
Fig. 85 Brazil
Fig. 86 Brazil market estimates and forecasts, 2018 - 2030
Fig. 87 Mexico
Fig. 88 Mexico market estimates and forecasts, 2018 - 2030
Fig. 89 Argentina
Fig. 90 Argentina market estimates and forecasts, 2018 - 2030
Fig. 91 Middle East and Africa
Fig. 92 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 93 South Africa
Fig. 94 South Africa market estimates and forecasts, 2018 - 2030
Fig. 95 Saudi Arabia
Fig. 96 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 97 UAE
Fig. 98 UAE market estimates and forecasts, 2018 - 2030
Fig. 99 Kuwait
Fig. 100 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 101 Market share of key market players- Hyaluronic Acid market